The Prognostic Significance of Expression of CA125 and Proliferation Markers and Architectural Type in Ovarian Clear Cell Adenocarcinoma
- 1 January 2000
- journal article
- Published by The Showa University Society in The Showa University Journal of Medical Sciences
- Vol. 12 (1) , 9-16
- https://doi.org/10.15369/sujms1989.12.9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian CancerGynecologic Oncology, 1996
- Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer?British Journal of Cancer, 1995
- Ovarian clear cell adenocarcinomaGynecologic Oncology, 1989
- Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.Journal of Clinical Pathology, 1988
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- “Mesonephroma” of ovary. Tumor of müllerian nature related to the endometrioid carcinomaCancer, 1967
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945
- On the mathematical foundations of theoretical statisticsPhilosophical Transactions of the Royal Society A, 1922